Late Stage Investors & VC Firms in United States
1520 firms in this list, with a median first check of $1M. 340 of them lead rounds. Generated from verified public data and updated continuously.
SparkLabs Korea
Palo AltoPre-Seed–Late Stage
5 people
ThornTree Capital Partners
BostonSeed–Late Stage
8 people
Gore Range Capital
SouthlakeSeed–Late Stage$500K – $5M
3 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
8 people
HCS Capital
MiamiSeed–Late Stage
5 people
PSG Equity
BostonLate Stage
8 people
Access Ventures (New York)
New YorkSeries B–Late Stage
2 people
Practical Venture Capital
San FranciscoGrowth–Late Stage
7 people
Westwood Holdings Group
DallasLate Stage
13 people
Brace Pharma
AtlantaLate Stage
3 people
Montreux Equity Partners
San FranciscoGrowth–Late Stage$10M – $20M
3 people
BreakawayGrowth Fund
San FranciscoPre-Seed–Late Stage
5 people
DRW Venture Capital
ChicagoSeed–Late Stage$1M – $5M
1 person
BC Partners
New YorkGrowth–Late Stage
6 people
Charlotte Fund
CharlottePre-Seed–Late Stage
6 people
Invert Up
San JosePre-Seed–Late Stage$25K
3 people
Martinson Ventures
PennsylvaniaGrowth–Late Stage$2M – $15M
3 people
Redhills Ventures LLC
Las VegasSeed–Late Stage$125K – $7M
3 people
Yieldstreet
New YorkGrowth–Late Stage$25K
GI Corporation
HoustonGrowth–Late Stage
5 people
Soleus Capital
GreenwichLate Stage
2 people
Firsthand Technology Value Fund
San JosePre-Seed–Late Stage$1M – $10M
1 person
Kombo Ventures
Los AngelesPre-Seed–Late Stage
1 person
Agility Capital
Santa BarbaraSeries C–Late Stage$250K – $1.5M
4 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Seed Investors & VC Firms (10975)Series A Investors & VC Firms (8160)Pre-Seed Investors & VC Firms (5955)Seed Investors & VC Firms in North America (5705)Investors & VC Firms in Europe (5528)Seed Investors & VC Firms in United States (5128)Growth Investors & VC Firms (4870)Series A Investors & VC Firms in North America (4605)
Data sourced from public filings and firms' own websites — see our methodology.





















































